Anish Suri's most recent trade in Cue Biopharma Inc was a trade of 150,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 05 Jun 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 06 Mar 2024 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 25 Aug 2023 | 4,000 | 135,638 (0%) | 0% | 2.8 | 11,040 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 21 Jul 2023 | 124,125 | 124,125 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 16 Feb 2023 | 125,500 | 125,500 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 31 Mar 2022 | 16,668 | 0 | - | - | Restricted Stock Units | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 31 Mar 2022 | 16,668 | 110,706 (0%) | 0% | - | Common Stock | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 31 Mar 2022 | 7,068 | 103,638 (0%) | 0% | 4.9 | 34,492 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 09 Feb 2022 | 82,000 | 82,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 09 Feb 2022 | 21,333 | 21,333 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 15 Nov 2021 | 8,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 15 Nov 2021 | 8,000 | 94,038 (0%) | 0% | 18.1 | 144,400 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 15 Nov 2021 | 8,000 | 102,038 (0%) | 0% | 8.3 | 66,080 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 11 Nov 2021 | 20,000 | 105,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 11 Nov 2021 | 20,000 | 94,038 (0%) | 0% | 15.1 | 301,354 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 11 Nov 2021 | 20,000 | 114,038 (0%) | 0% | 6.4 | 128,400 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 03 Oct 2021 | 33,334 | 108,172 (0%) | 0% | - | Common Stock | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 03 Oct 2021 | 33,334 | 0 | - | - | Restricted Stock Units | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 03 Oct 2021 | 14,134 | 94,038 (0%) | 0% | 13.0 | 183,318 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 23 Sep 2021 | 20,000 | 125,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 23 Sep 2021 | 20,000 | 74,838 (0%) | 0% | 15.2 | 304,646 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | PRESIDENT AND CSO | 23 Sep 2021 | 20,000 | 94,838 (0%) | 0% | 6.4 | 128,400 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 10 Feb 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Oct 2020 | 33,333 | 67,891 (0%) | 0% | - | Common Stock | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Oct 2020 | 33,333 | 33,334 | - | - | Restricted Stock Units | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Oct 2020 | 9,800 | 58,091 (0%) | 0% | 16.3 | 159,740 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 05 Aug 2020 | 800 | 35,358 (0%) | 0% | 6.4 | 5,136 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 05 Aug 2020 | 800 | 145,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 05 Aug 2020 | 800 | 34,558 (0%) | 0% | 20.0 | 16,008 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 5,800 | 34,558 (0%) | 0% | 20.0 | 116,058 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 3,800 | 40,358 (0%) | 0% | 6.4 | 24,396 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 3,800 | 146,200 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 2,000 | 18,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 2,000 | 36,558 (0%) | 0% | 8.3 | 16,520 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 400 | 34,958 (0%) | 0% | 6.4 | 2,568 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 400 | 34,558 (0%) | 0% | 20.1 | 8,056 | Common Stock | |
| Cue Biopharma Inc | Anish Suri | President and CSO | 03 Aug 2020 | 400 | 145,800 | - | - | Stock Option (right to buy) |